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Abstract
Background and Methodology: Pancreatic beta cells show intercellular differences in their metabolic glucose sensitivity
and associated activation of insulin production. To identify protein markers for these variations in functional glucose
sensitivity, rat beta cell subpopulations were flow-sorted for their level of glucose-induced NAD(P)H and their proteomes
were quantified by label-free data independent alternate scanning LC-MS. Beta cell-selective proteins were also identified
through comparison with rat brain and liver tissue and with purified islet alpha cells, after geometrical normalization using 6
stably expressed reference proteins.
Principal Findings: All tissues combined, 943 proteins were reliably quantified. In beta cells, 93 out of 467 quantifiable
proteins were uniquely detected in this cell type; several other proteins presented a high molar abundance in beta cells. The
proteome of the beta cell subpopulation with high metabolic and biosynthetic responsiveness to 7.5 mM glucose was
characterized by (i) an on average 50% higher expression of protein biosynthesis regulators such as 40S and 60S ribosomal
constituents, NADPH-dependent protein folding factors and translation elongation factors; (ii) 50% higher levels of enzymes
involved in glycolysis and in the cytosolic arm of the malate/aspartate-NADH-shuttle. No differences were noticed in
mitochondrial enzymes of the Krebs cycle, beta-oxidation or respiratory chain.
Conclusions: Quantification of subtle variations in the proteome using alternate scanning LC-MS shows that beta cell
metabolic glucose responsiveness is mostly associated with higher levels of glycolytic but not of mitochondrial enzymes.
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Introduction
Insulin-producing beta cells are the body’s central glucose
sensors. Key to their glucose sensing, is their dependence on low-
affinity glucose phosphorylation by glucokinase [1,2]. Freshly
isolated beta cells reveal heterogeneity in metabolic glucose
sensitivity [3]. Intercellular variations in glucokinase abundance
and activity give rise to proportionate variations in concentration-
response curves for glucose-induced NAD(P)H, insulin synthesis
and secretion [2,4–7]. This functional heterogeneity is subject to
regulation in vivo – as shown in animals exposed to sulfonylurea
[8]-, and likely contributes to normal glucose tolerance. Beta cells
with higher glucose sensitivity are also less susceptible to oxidative
damage [6,9]. Glucose intolerance and type 2 diabetes is thought
to involve progressive beta cell exhaustion, provoked by sustained
metabolic overload, leading to loss of glucose sensitivity [10].
Understanding how intrinsic glucose sensitivity is reflected in the
beta cell proteome can guide us to markers to study functional
adaptations in the beta cell mass in vivo, and ultimately to therapy
that can regulate it. Such natural variations in glucose sensitivity
are likely explained by minor variations along a normal
distribution of enzyme abundances rather than by dichotomous
absence/presence of key enzymes. Disclosing such specializations
requires precise and accurate quantifications. Data-independent,
alternate-scanning LC-MS is an ion current based mass
spectrometric analysis method that offers label-free quantification
of molar protein abundances [11,12]. The present study first
evaluated if alternate scanning LC-MS achieves sufficient accuracy
and precision to measure functional sub-specializations within a
pure cell type at the protein level. A second aim was to describe
protein markers that are quantitatively associated with the beta
cells’ metabolic responsiveness to glucose. Finally, through a tissue-
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comparative analysis, an attempt was made to catalog protein
markers with selective expression in insulin-producing beta cells.
Results
Dynamic range of detected proteomes
Molar protein amounts in FACS-purified rat islet beta and
alpha cells were measured, and compared to whole liver and brain
proteomes [11]. A total of 943 proteins were identified in liver,
brain, alpha and beta cells. The number of identifications in a
single tissue ranged from 346 (brain) to 527 (liver). Within each
tissue, the most abundant proteins were 200 to 600-fold more
present than the lowest detectable ones that still could be reliably
quantified (Table 1). The important overlap of the 4 tissue
proteomes reflects that identified proteins typically belong to
abundant functional pathways, with in decreasing order: cytoskel-
eton constituents, metabolic enzymes and proteins involved in
protein biosynthesis and intracellular signaling (Fig. 1a). Islet
endocrine alpha and beta cells showed highest similarity (Fig. 1b).
Liver had the highest number of identifications; consequently,
molar amounts in liver were in average 4-fold lower than in
endocrine and neural cells (Table 1). Quantitative comparison of
tissue proteomes thus requires normalization to reference proteins
with stable expression between tissues (Fig. S1); 6 such references
belonging to 3 different functional pathways, were selected for
geometric [13] normalization of molar amounts as specified in
Experimental procedures and Fig. S1: 2 cytoskeleton- (Tubb5,
Pfn1), 2 signaling- (Ywhae, Rab1b) and 2 protein synthesis (Ppia,
Hspa8)-associated proteins, and spread over a concentration range
of 2 decades.
Validity of alternate-scanning LC-MS-based beta cell
proteome quantification
Total imprecision (error) – reflecting true biological variation plus
the variation attributable to protein extraction, sample processing
and LC-MS analysis – was limited to 19% (median) for the beta
cell Fig. 2. Analytical imprecision calculated as variation solely on
triplicate MS injections (Fig. 2) was limited to 14–17% (median).
With such precision, molar protein expression differences between
cell types down to 45% can be confidently discerned (see
Experimental procedures).
Next, accuracy (bias) of the quantitative label-free LC-MS
analyses was evaluated. The stoichiometry of subunits within
multienzyme complexes such as mitochondrial F0F1-ATPase,
pyruvate- (PDH) and oxoglutarate- (OGDH) dehydrogenase
complexes has been extensively studied, and can serve as
reference. In liver tissue, most subunits of these macrocomplexes
were identified. As shown in Fig. 2b-c the relative ratios of their
subunits as measured by LC-MS closely matches the previously
reported stoichiometries. For the PDH complex the E1a:E1-
b:E2:E3 ratios of 40:40:40:20 were confirmed [14]. A similarly
good approximation was obtained for OGDH with E1:E2:E3
ratios previously reported of 12:24:6 [15]. Also the F1-domain of
the mitochondrial F0F1-ATPase, label-free quantitative LC-MS
approached the known 3-fold higher expression of catalytic
subunits a and b as compared to other F1-stalk subunits. Overall,
accuracy for measurement of subunit stoichiometry is 104625%.
The proteome of beta cell subsets with higher or lower
metabolic and functional glucose responsiveness
Since the applied LC-MS scanning technology can accurately
detect moderate molar expression differences in a label-free, ion
current fashion down to 45%, it was used to identify variations in
enzyme abundances as function of the beta cells’ metabolic glucose
sensitivity. Glucokinase activity is to date the only in vitro [2,4,5]
and in vivo [8] functional marker for glucose sensing capacity of
individual beta cells. Beta cells were stimulated with 7.5 mM
glucose – a concentration close to the Km of glucokinase - and
FACS-sorted for their level of glucose-derived NAD(P)H (Fig. S2).
Beta cells with higher glucose-induced NAD(P)H have a higher
subcellular complexity (light side scatter) despite similar insulin
stores [16]; their radius (forward light scatter) is on the average
11% larger (p,0.05) (Fig. S2a–b), indicating 1.35 times larger
intracellular volume. This corresponds well with earlier studies
from our group (1.25 times [2]) and others (1.32 times, [17]), and
with the higher total protein level per cell (316642 pg/cell in
highly versus 193652 pg/cell in lowly responsive beta, p = 0.12,
n = 3). Even when cellular protein synthetic activities were
corrected for difference in cell size, the highly glucose responsive
phenotype retained a 1.5–2-fold higher insulin production per cell,
reflecting size-independent intrinsic activation. For LC-MS
analysis, an identical protein amount of each phenotype was
Table 1. Overview of protein identifications and quantifications.
a cells b cells liver brain High b Low b
Number of proteins
identified 353 467 527 346 254 256
quantified 342 434 505 341 232 229
* Amount of protein
median 0.001484 0.001954 0.001521 0.001711 0.002814 0.002577
minimum 0.000057 0.000092 0.000159 0.000098 0.000069 0.000120
** maximum 0.027730 0.052581 0.025761 0.027860 0.042239 0.046572
dynamic range (log) 2.63 2.75 2.21 2.45 2.78 2.59
*target protein (ng) detected on column/total amount protein (ng) detected on column.
**excluding top 1% percentile.
A first round of LC-MS analysis compared FACS-purified pancreatic alpha and beta cells (n = 3) to whole liver and brain tissue pools. A second independent analytical
round compared rat beta cells that were sorted for their metabolic responsiveness (glucose-induced NAD(P)H) shortly after their isolation. ‘High’ and ‘low beta’ indicate
respectively beta cells with higher or lower metabolic glucose responsiveness, as reflected by their level of 7.5 mM glucose-stimulated NAD(P)H production (See Fig. S2,
Methods). The table shows number of proteins identified (above limit of detection), quantified (above limit of quantification) and general quantitative properties of the
proteomes.
doi:10.1371/journal.pone.0014214.t001
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injected for comparison. This resulted in equal detection of the 6
chosen reference proteins (Ppia, Hspa8, Rab1b, Ywhae, Tubb5, Pfn1):
with their mean expression ratio in highly/lowly responsive cells of
1.0560.05 (n = 3, range 0.90–1.19), the data enabled direct
comparison of molar protein levels between phenotypes without
additional normalization. Overall, LC-MS detected 254 (256)
proteins in highly (lowly) glucose-responsive subpopulations – of
which 232 (229) above limit of quantification and 90% (215)
overlapping identifications (Table S2).
Highly glucose-responsive beta cells have 50% higher
expression of protein synthetic machinery
Highly glucose-responsive cells expressed more 40S and 60S
ribosomal protein: 6 ribosomal subunits were only detected in highly
glucose responsive beta cells; commonly detected ribosomal
subunits were 1.5 times (95% CI 1.2–1.8) more abundant in
highly glucose responsive beta cells. These cells also expressed
50% more translation elongation proteins (both eEF1 and eEF2)
(Fig. 3). Median molar amount of 30 endoplasmic reticulum (ER)-
associated proteins was 1.5-fold higher (average 6.962.4-fold, range
0.16–44 fold) in highly versus lowly responsive cells (Table S2).
Examples in Fig. 3 are the NADPH-dependent protein disulphide
isomerases, which mediate protein folding. Highly responsive cells
also express more coatomer-complex proteins, important for
normal trafficking of secretory proteins from ER to cis-Golgi [18].
In line with these changes, highly responsive beta cells synthesized
2 to 3-fold more protein than lowly responsive beta cells ((Fig. 3,
Fig. S2) and [2,16]).
Higher glucose responsiveness correlates with higher
glycolytic enzyme expression
Glucokinase protein was below the limit of detection in liver and
beta cells. The highest expression of glycolytic enzymes was found
in brain. Molar levels of individual glycolytic enzymes showed
strong variations with .100-fold difference in number of
molecules of most abundant and lowest detectable enzymes, e.g.
in liver glyceraldehyde-3-phosphate dehydrogenase (Gapdh) versus
phosphofructokinase (Pfkl) (Fig. 4a–b). Relative amounts of
individual enzymes were comparable in the 4 tissues studied, with
overall enzymes proximal to the lytic aldolase step systematically
less abundant than distal enzymes, or even undetectable – as in
high/low beta cell comparison. Of note, LC-MS could correctly
discern tissue-restricted isoforms, such as abundant aldolase B
(Aldob) only in liver and distribution of enolase isoforms in brain
Figure 1. Overview of detected proteomes. Panel A. shows functional pathways that are statistically enriched in the detected proteomes
(p,0.001); for each pathway (gene ontology), the average protein level, after geometric normalization, is shown for each of 4 tissues so that relative
importance of these pathways can be quantitatively estimated between tissues. Venn diagram in panel B. shows the number of protein
identifications in each tissue and their overlaps denoting overall proteome similarity.
doi:10.1371/journal.pone.0014214.g001
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(Fig. 4b). In pancreatic beta cells, pyruvate kinase (muscle isoform,
Pkm2) was the most abundant glycolytic enzyme.
Beta cells with higher metabolic glucose responsiveness
expressed on average 46% (range 16–200%) higher levels of
glycolytic enzymes than lowly responsive cells (Fig. 4a). Increased
glycolytic enzymes were coupled to a 50% higher expression of the
cytosolic arm of the malate/aspartate NADH shuttle: aspartate
aminotransferase 1 (Got1, 44% up) and malate dehydrogenase 1
(Mdh1, 77% up) (Fig. 5a). High Mdh1 appeared as metabolic
specialization of beta cells with 4-fold higher expression than liver
and alpha cells, and 2-fold more than brain (Fig. 5b), in line with
established role of this shuttle in glucose-stimulus secretion
coupling [19].
These findings suggest that glucose flux in beta cells is not only
constrained at the glucokinase step, but also below. Indeed: highly
glucose responsive beta cells also oxidized 30% more D-
glyceraldehyde (Fig. 5c, p,0.05), a triose that enters triose
phosphate isomerase step, and thus short-cuts glucokinase.
High glucose responsiveness is not associated with
higher mitochondrial enzyme expression
Despite their 2 fold higher glucose oxidation rate ([16,20] and
Fig. 5c), highly responsive beta cells show no major difference in
expression of the mitochondrial branch of the NADH shuttle (Got2
and Mdh2), various TCA cycle enzymes (Mdh2, Idh2, Aco2) or even
the anaplerotic enzyme pyruvate carboxylase (Pc) (Fig. 5a). Two
flavin cofactor-containing enzymes reached detection limit only in
the highly responsive cells, namely subunits from pyruvate
dehydrogenase (Dld) and electron transfer flavoprotein (Etfb).
Figure 2. Validity of LC-MS quantifications. A. Imprecision (error): beta cell proteins of 3 independent cell isolations (A, B, C) were injected in
triplicate. Box and whiskers plots tA, tB and tC represent analytical variation on technical replicate LC-MS injections. Median and average values are
represented by black and white triangles, respectively, with 95% confidence interval shown in grey. Total experimental imprecision (analytical +
biological variation) is shown in b1 (normalized here for Gapdh) and b2 (total amount normalization). B–C. Accuracy (bias) was evaluated taking
stoichiometry of multienzyme complexes as reference. Bar graphs represent geometrically-normalized protein levels (black bars, mean of n = 3) of
indicated enzyme subunits measured by LC-MS in liver tissue; corresponding NCBI gene symbols are mentioned in italic capitals. Gray bars shows
expected complex stoichiometry based on literature consensus. Panel B shows related pyruvate dehydrogenase (PDH) and oxoglutarate
dehydrogenase complexes (OGDH). Panel C shows F1 unit of mitochondrial F0F1 ATP synthase. BCKD E2 subunit was absent in protein search library.
doi:10.1371/journal.pone.0014214.g002
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Unlike neuronal cells (Fig. 5b), beta cells express significant
amounts of fatty oxidation enzymes, but their levels are not clearly
associated with glucose responsiveness. LC-MS analysis confirmed
the discrepantly high level of L-3-hydroxyacyl-CoA dehydroge-
nase (Hadh, formerly Hadhsc) in the beta cell beta-oxidation chain
(Fig. 5b) [21]. Together with Gapdh, Pkm2, and Mdh1, the Hadh
enzyme ranks among the most abundant enzymes in the beta
cell.
High glucose sensitivity of freshly isolated beta cells is in
part mimicked by sustained glucose stimulation in vitro
Beta cells that are chronically stimulated by glucose $10 mM
become basally hyper-activated, with left-shift of the concentra-
tion-response curves for glucose-stimulated insulin synthesis,
secretion and metabolic activation [6,22,23]. Published proteome
profiles of mouse pancreatic islets, exposed for 24 h to high glucose
(16.7 mM) versus basal (5.6 mM) [24], were compared to profiles
of rat beta cells with high or low glucose sensitivity. Thirty proteins
could be directly compared in both data sets (Fig. 6a). The major
adaptations in high glucose-exposed beta cells (Fig. 6b) were
increased expression of glycolysis, associated to higher expression
of the protein biosynthetic machinery (ribosome, protein folding),
just like in freshly isolated beta cells with higher glucose sensitivity.
TCA cycle proteins were not heavily regulated.
Quantitative view on proteins only detected in beta cells
93 of 943 proteins were below the detection limit of our LC-MS
configuration in all assayed tissues, except the beta cells (Table 2).
These include known beta cell markers (Glut2, Pcksk1, Sytl4) and
several novel candidate beta cell markers. Functionally, these
markers are enriched in ontologies involved in hormone synthesis,
processing and regulated secretion. Molar abundances are
generally 5 to 10-fold lower than those of reference proteins
cyclophilin A (Ppia) and 14-3-3 protein epsilon (Ywhae). Yet, many
fall well above our limit of quantification and even rank among the
top 35% most abundant proteins of our whole data set (943
proteins): e.g. Golgi proteins such as Copb2 and Gosr2, plasma
membrane (associated) proteins such as Drd3, Adrbk1 and Gpsm1,
Figure 3. Higher protein synthetic activity of metabolically highly responsive beta cells is associated with concerted up-regulation
of protein synthetic machinery. Panels from left to right counterclockwise: molar expression of small (40S) and large (60S) ribosomal subunits,
mRNA translation elongation factors, endoplasmic reticulum-proteins involved in NADPH-regulated protein folding (protein disulphide isomerase
family, Pdia), and subunits of the coatomer complex, involved in protein trafficking between endoplasmic reticulum and Golgi for regulated
secretion. Concerted 50% protein up-regulation is associated to 2-fold higher 3H-Tyrosine incorporation, over 0–10 mM glucose range (blue square
inset). Lowly and highly responsive beta cells represented by pale and dark blue bars respectively; absent bars indicate protein level below limit of
quantification.
doi:10.1371/journal.pone.0014214.g003
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glycerol-phosphate shuttle protein Gpd2, and several enzymes of
short chain fatty acid metabolism (Echs1, Echdc1).
Discussion
Validity of alternate-scanning LC-MS for proteome
quantification
Our study took two approaches to investigate protein markers
for glucose sensitivity of beta cells: (i) tissue-comparative analysis to
highlight (relatively) beta cell-selective expression, and (ii) a
comparison of beta cell phenotypes that were sorted for their
natural variations in metabolic glucose responsiveness. Since both
comparisons rely on adequate quantification of molar protein
abundances, the analytical validity of our technique was first
evaluated. It provided acceptable sensitivity in terms of number of
proteins identified under statistically stringent criteria. Evidently,
the inherent constraints in dynamic range of mass spectrometry
(MS), limit quantification of unfractionated cellular proteomes to
the upper 2 to 3 orders of most abundant proteins: the dynamic
ranges of 200–600 observed in our study agree with previous
reports of dynamic ranges of 2.7 or 3.5 for quantification or
detection respectively [25]. Of note, detection and identification of
proteins also depends on extraction method and fractionation of
classes of interest, which is the subject of a separate study. The MS
technique was also found to be accurate - as judged from its
unbiased prediction of multienzyme subunit stoichiometry - and
technically precise: in combination with the standardized beta cell
isolation procedures [26], overall imprecision – including true
biological variation - was limited to 620%. Consequently,
differences in molar abundance of individual proteins between
cells down to 45% - a value corresponding to a full width at half
maximum (FWHM) of the normal distribution - can be confidently
discerned.
For tissue-comparative analyses, protein abundances were
geometrically normalized towards the abundance of multiple
stably expressed reference proteins [13]. A pair of proteins
qualifies as reference or ‘‘housekeeping’’ proteins when their ratio
varies minimally across different cell or tissue types. Our 6
reference proteins were additionally chosen from different
functional pathways to avoid selecting truly co-regulated proteins.
Ppia, Hspa8, Tubb5, Pfn1, Ywhae and Rab1b were selected in the
tissue-comparative data set, and successfully validated in the
independently acquired data set on highly/lowly glucose respon-
sive beta cells. Metabolic enzymes such as Mdh2 and Gapdh
Figure 4. High glucose responsiveness is associated with higher molar expression of glycolytic enzymes. Comprehensive view on all
enzymes of glycolysis detected in highly (black bars) and lowly (gray) glucose responsive beta cells (panel A, fmolr representing relative molar
amount units, non-normalized) and in rat tissues (B, GEOnorm indicates geometrically-normalized units using 6 reference proteins). Enzymes from
start to end of the pathway are represented sorted from bottom (proximal glycolysis) to top (distal glycolysis). Enzymes denoted by their NCBI gene
name; absent bars indicate protein level below limit of quantification.
doi:10.1371/journal.pone.0014214.g004
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appeared suboptimal as reference: e.g. neurons express clearly
higher levels of glycolytic enzymes such as Gapdh (Fig. S1). Of note,
if Gapdh were chosen as reference for highly/lowly glucose sensitive
beta cells, much of their observed differences would remain
unnoticed, illustrating the inevitable introduction of interpretative
bias by normalizing.
Enzymes with beta cell selective expression in terms of
molar abundance
Several enzymes with established role in stimulus-secretion
coupling showed beta cell-selective expression in terms of high
molar abundance: L-3-hydroxyacyl-CoA dehydrogenase (short
chain) (Hadh, formerly Hadhsc) [21,27], pyruvate carboxylase (Pc)
[28], cytosolic malate dehydrogenase (Mdh1) [19] and glycerol-3-
phosphate dehydrogenase (Gpd2) [29] – the latter two central to
the shuttles that transport glycolysis-derived reducing equivalents
(NADH, FADH2) into the mitochondria. A novel and intriguing
feature is the beta cell selective expression of several enzymes with
presumed role in mitochondrial short-chain fatty acid metabolism:
though not differentially expressed as function of natural glucose
sensitivity, the roles of Acads, Echs1 and Echdc in nutrient sensing
certainly requires further study, e.g. in the context of acetoacetate-
induced insulin secretion and coupling role of short-chain acyl-
CoAs [30].
Proteins associated with intercellular differences in beta
cell glucose sensitivity
The classical glucose sensor enzyme, glucokinase (Gck) [31], was
below the MS detection limit. Low molar Gck abundance fits with
the low levels of its mRNA (3, 8 and 240 times lower than that of
respectively Gad2, Hadh and Slc2a2/Glut2, our unpublished data).
It also fits with the present finding that enzymes of proximal
glycolysis are rare as compared to those downstream of the
aldolase step. Gck is an accepted marker of beta cell glucose
sensitivity [7], and its loss- or gain-of-function mutations in
humans result respectively in loss of or excessive glucose sensing
[31]. Our group first described the technique to flow-sort rodent
beta cells for their level of metabolic glucose sensitivity: beta cells
accumulate NAD(P)H when glucose stimulated, and do so in
sigmoid kinetics with half-maximal NAD(P)H at glucose ,
7.5 mM, around the Km of Gck [6]. This glucose concentration-
dependent activation of metabolism, results in progressive
recruitment of more beta cells into a state of activated insulin
synthesis [4] and secretion [5], whereby the activation threshold of
individual beta cells correlates with their Gck expression and
activity [2]. The glucose concentration-dependence of insulin
production by the total beta cell population thus appears regulated
by normal variations in the underlying glucose sensitivity of the
individual beta cells, resulting in a response that fits the normal
Figure 5. glucose responsiveness and sugar oxidation rates are not associated with mitochondrial enzyme expression. Panel A shows
enzyme expression in low (gray) or high (black) responders (molar amount units), with in panel B the corresponding GEO-normalized protein levels in
rat tissues. Shown are malate/aspartate shuttle enzymes (cytosolic arm:Mdh1, Got1; mitochondrial arm:Mdh2, Got2), Krebs cycle enzymes (Mdh2,
Idh2, Aco2), Pdh complex unit Dld, anaplerotic enzyme pyruvate carboxylase Pc, and various beta oxidation enzymes (Hadha, Hadh, Acat1, Etfa, Etfb).
Panel C shows mitochondrial oxidation rates from hexose (5 mM D-glucose) or triose (1 mM D-Glyceraldehyde) sugar in highly (black) or lowly (gray)
responsive beta cells. Data represent mean6SD (n = 4) with ** p,0.001 and * p,0.05 in high versus low. Absent bars indicate protein level below
limit of quantification.
doi:10.1371/journal.pone.0014214.g005
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distribution with average activation around the Km of Gck.
Dichotomous sorting of the beta cell population for 7.5 mM
glucose-induced NAD(P)H thus yields the two tails of the normal
population (Fig. S2), and provides a unique view on functionally
relevant proteome variations within a pure (695% insulin-
positive) cell population.
The higher protein synthetic capacity of highly glucose sensitive
beta cells was reflected in a 650% up-regulation of all stages in
their protein production line: from ribosome over translational
control, to protein folding (Ppia family) in endoplasmic reticulum
(ER) and ER to Golgi transport (coatomer complex) for secretion.
The picture was not comprehensive - with several other likely
regulators [32], such as translation initiation factors and S6 kinase
not detected – but its consistency with cellular function serves as
positive control.
Abundant Mdh1 was not only characteristic for beta cells, its
level also correlated with glucose sensitivity of the beta cells. In
highly responsive beta cells, the 50% higher Mdh1 was paralleled
with 46% (16–200%) higher level of glycolytic enzymes. These
cells oxidize glucose and D-glyceraldehyde respectively 2-fold and
30% more than lowly responsive beta cells: the former corresponds
to their previously reported 2-fold higher Gck activity [2], the latter
matches their overall higher glycolytic capacity – since D-
glyceraldhyde enters at the level of glyceraldehyde-3-phosphate,
independent of Gck [16]. Our study thus emphasizes the
importance of glycolysis and transport of derived NADH into
the mitochondria in regulation of glucose sensing. It is in line with
the previously reported role of distal glycolytic intermediates in
nutrient-regulated beta cell function [33].
These findings do not argue against the crucial role of
mitochondrial nutrient oxidation and NADH (re)generation in
stimulus-secretion coupling [34], but indicate that molar abun-
dances of mitochondrial metabolic enzymes are not limiting
oxidative sugar flux: several enzymes of Krebs cycle, electron
transport and fatty acid oxidation could be studied, but none
correlated with glucose sensitivity. Neither did the level of
pyruvate carboxylase, though its anaplerotic activity is crucial for
beta cell function [35].
Cell size and intrinsic activity synergistically account for
higher protein synthesis of beta cell subsets with higher
glucose sensitivity
The highly glucose responsive beta cells have a larger cell
volume (630%) and contain more protein per cell than lowly
responsive beta. Of note, these values are averages and appear
normally distributed within each sorted subset. An identical
protein amount of both phenotypes was injected into the LC-MS;
the fact that this resulted in statistically similar detection of the 6
chosen reference proteins, indicates that our chosen references
indeed qualify as ‘housekeepings’, and that increased size/total
protein content of highly responsive beta cells is associated with a
proportionate increase of all 6 ‘housekeepings’. Reference protein-
normalized protein levels thus reflect the size-independent or
Figure 6. The phenotype of highly glucose responsive beta cells is partly mimicked by sustained glucose stimulation ex vivo. Of 93
proteins, 57 (61%) were up-regulated by 24 h 16.7 mM as compared to 5.6 mM glucose, and 36 (39%) down-regulated (p,0.05) in mouse islets [24].
Panel A shows their NCBI gene name in a plot, indicating their relative amount in highly/lowly glucose-responsive rat beta (Y-axis) and 16.7/5.6 mM
glucose-exposed mouse islets. In blue, proteins of glycolysis; in green, protein biosynthesis; in orange, mitochondrial; in black: miscellaneous (Prdx3,
Cfl1, Rps18, Rplp1, Park7 out of scale). Panel B shows % of glucose-regulated proteins (black: glucose-induced, gray: glucose-suppressed) that belong
to indicated functional ontologies. For 30 of 93 proteins, molar abundances could be measured in rat highly/lowly glucose-responsive beta cells.
doi:10.1371/journal.pone.0014214.g006
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Table 2. Proteins identified only in the beta cells.
Ontology Symbol Gene name percentile molar amount
(%) GEOnorm
Endoplasmic reticulum, Golgi apparatus and secretory vesicles
Gosr2 golgi SNAP receptor complex member 2 90 0.8865
Copb2 coatomer protein complex, subunit beta 2 (beta prime) 70 0.3747
Ufm1 ubiquitin-fold modifier 1 65 0.3604
Pcsk1 proprotein convertase subtilisin/kexin type 1 65 0.3285
Sytl4 synaptotagmin-like 4 60 0.3080
Sec31a SEC31 homolog A (S. cerevisiae) 55 0.2466
Sec13 SEC13 homolog (S. cerevisiae) 55 0.2414
Uso1 USO1 homolog, vesicle docking protein (yeast) 50 0.2209
Prrc1 proline-rich coiled-coil 1 40 0.1830
Bnip1 BCL2/adenovirus E1B 19 kDa-interacting protein 1 30 0.1268
Gorasp2 golgi reassembly stacking protein 2 30 0.1327
Nsfl1c NSFL1 (p97) cofactor (p47) 20 0.0960
Nsfl1c NSFL1 (p97) cofactor (p47) 20 0.0960
Rnpep arginyl aminopeptidase (aminopeptidase B) 15 0.0768
Intracellular signaling
Adrbk1 Adrenergic, beta, receptor kinase 1 90 1.1449
Drd3 dopamine receptor D3 90 1.2612
Tpt1 tumor protein, translationally-controlled 1 80 0.5835
Ppp1r1a protein phosphatase 1, regulatory (inhibitor) subunit 1A 65 0.3683
Gpsm1 G-protein signaling modulator 1 (AGS3-like, C. elegans) 55 0.2456
Map2k1 mitogen activated protein kinase kinase 1 30 0.1378
Camk2d calcium/calmodulin-dependent protein kinase II delta - nq
Camk2a calcium/calmodulin-dependent protein kinase II alpha - nq
Camk2g calcium/calmodulin-dependent protein kinase II gamma - nq
Metabolism
Echs1 enoyl Coenzyme A hydratase, short chain, 1, mitochondrial 65 0.3315
Echdc1 enoyl Coenzyme A hydratase domain containing 1 60 0.2786
Ddc dopa decarboxylase (aromatic L-amino acid decarboxylase) 60 0.2903
Gpd2 glycerol-3-phosphate dehydrogenase 2, mitochondrial 55 0.2506
Aco1 aconitase 1, soluble 50 0.2151
Cox5b cytochrome c oxidase subunit Vb 50 0.2205
Aldh7a1 alpha-amino adipic semialdehyde dehydrogenase (antiquitin) 45 0.2076
Atp6v1e1 ATPase, H+ transporting, lysosomal V1 subunit E1 45 0.2012
Slc2a2 facilitated glucose transporter 2 35 0.1532
Aldh6a1 methylmalonate semialdehyde dehydrogenase 30 0.1386
Ddt D-dopachrome tautomerase 30 0.1347
Acaa1a acetyl-Coenzyme A acyltransferase 1 (peroxisomal) 25 0.1023
Sardh sarcosine dehydrogenase 25 0.1074
Acads acyl-Coenzyme A dehydrogenase, short chain 15 0.0716
Cell motility and cytoskeleton
Vcl vinculin 50 0.2149
Wdr1 WD repeat domain 1 50 0.2195
Dctn2 dynactin 2 45 0.2066
Dcx doublecortin 25 0.1123
Tpm4 tropomyosin 4 20 0.0940
Fis1 fission 1 (mitochondrial outer membrane) homolog (S. cerevisiae) 20 0.0954
Capzb capping protein (actin filament) muscle Z-line, beta 10 0.0644
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‘intrinsic’ functional properties. At first sight, there appeared a
discrepancy between the relatively moderate (61.5-fold) higher
expression of glycolysis and protein synthetic machinery in the
highly responsive beta cells, and their 2 to 3-fold higher actual
protein synthetic rates (Fig. S2c). This discrepancy is resolved
when also the 1.3-fold size differences are taken into account, and
both factors are synergistically (1.361.5 = 2) combined to explain
actual functional differences. This is summarized in the scheme of
Fig. S2d.
Consistency with other models
The ‘natural’ variations in glucose sensing are partly recapit-
ulated by two in vitro models. A first is the loss of glucose
sensitivity of MIN6 insulinoma cells after long-term culture [36];
the second is the proteome adaptations of primary beta cells to
high glucose concentrations [24].
In the first model, Clynes et al. reported mRNA and proteome
adaptations in MIN6 insulinoma cells with progressive loss of
glucose sensitivity in culture [36]. Of note, they [37], and others
[38], found a limited correlation between mRNA and proteome
adaptations, underlining the importance of proteome studies.
They identified 35 proteins as differentially regulated with varying
glucose sensitivity: high sensitivity correlated with increased
expression of ER proteins, including the NADPH-dependent Pdia
family also emphasized in our study. Another parallel was that
high glucose sensitivity correlated with high peroxiredoxin and
superoxide dismutase 1 expression, suggesting that oxidative
radical scavenging preserves normal glucose sensing. Besides, beta
cells had relatively abundant expression of peroxiredoxin and
superoxide dismutase enzymes as compared to other tissues (Table
S1), contrary to the widely held notion of their poor oxidative
scavenging capacity [39]. Also in MIN6 cells, high glucose
sensitivity was associated with high Mdh1, elevated expression of
several – but not all – glycolytic enzymes and no detectable
differences in mitochondrial enzymes.
As second model, sustained stimulation with glucose .10 mM
brings beta cells into a functional state that is partly reminiscent of
in vivo high glucose sensitivity: left-shift of the glucose-induced
metabolic activation (NAD(P)H) and insulin production [22],
correlated with increased mRNA expression of glucose-cataboliz-
ing enzymes, endoplasmic reticulum (ER) proteins and secretory
vesicle-associated proteins [40,41]. A major difference is that
sustained high glucose in vitro provokes basal secretory hyper-
activation leading to cellular exhaustion partly due to depletion of
insulin content. Waanders et al. confirmed this at the protein level
[24]: 24 h high glucose (16.7 mM versus 5.6 mM) activated
glycolytic enzymes, and multiple ER proteins involved in protein
folding and processing; also it activated ROS-scavenging proteins
such as Prdx3 but down-regulated vesicle-associated proteins
(Vamp2). Similarly; increased expression of glycolytic enzymes
and ER proteins was found in the highly glucose sensitive beta
cells, as well as increased expression of several peroxiredoxins
(Prdx3, Prdx5 and to a lesser extent Prdx1 and Prdx2) and down-
regulated level of secretory granule-associated proteins (Vamp2,
Chga, Scg3). A major difference consists in the up-regulation of
mitochondrial metabolic (TCA) enzymes after sustained high
glucose, but not in the naturally highly glucose sensitive cells.
Can our findings be translated to a clinical context? Lu et al.
performed a careful in-depth study of loss of beta cell glucose
sensitivity in MKR mice, a rodent model of type 2 diabetes [42].
MKR beta cells initially adapt well to insulin resistance, but with
time lose function leading to hyperglycemia. Their phenotype
Ontology Symbol Gene name percentile molar amount
(%) GEOnorm
Tpm1 tropomyosin 1, alpha 5 0.1831
Proteasome
Psmc3 proteasome (prosome, macropain) 26S subunit, ATPase 3 45 0.1946
Psmc2 proteasome (prosome, macropain) 26S subunit, ATPase 2 20 0.0858
Psmc5 proteasome (prosome, macropain) 26S subunit, ATPase, 5 15 0.0777
Protein synthesis - translation
Wars tryptophanyl-tRNA synthetase 40 0.1799
Gars glycyl-tRNA synthetase 40 0.1657
Tars threonyl-tRNA synthetase 30 0.1275
Asns asparagine synthetase 20 0.0988
Sars seryl-tRNA synthetase 15 0.0673
6 reference proteins present in all tissues and used for GEOnormalization
Tubb5 tubulin, b5 - 2.0417
Ppia peptidylprolyl isomerase A (cyclophilin A) - 2.0273
Hspa8 heat shock protein 8 - 1.2830
Ywhae 14-3-3 protein epsilon - 1.0002
Pfn1 profilin 1 - 0.7672
Rab1b RAB1B, member RAS oncogene family - 0.2454
93 proteins were only identified in the beta cells. Table 2 shows a selection of proteins, from statistically overrepresented (p,0.005) functional ontologies. Percentile (%)
score ranks the proteins molar abundance (not normalized) to those of all other 943 identified proteins in tissue-comparative analysis with 100% = highest abundance.
GEOnorm molar amount represents measured molar units, normalized to the 6 stably expressed proteins that are shown as reference at bottom of the table.
doi:10.1371/journal.pone.0014214.t002
Table 2. Cont.
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presumably reflects both the initial attempts to adapt to increased
insulin demands, and with time accumulates signs of decompen-
sation. Though comprehensive comparison is complex, MKR beta
cells share global proteome fingerprints with highly glucose
sensitive beta cells, with increased expression of glycolytic
enzymes, Mdh1, many ER- and protein translation-associated
proteins, and Golgi markers such as Copb2. A major difference
here is the global suppression of TCA enzyme and electron
transport proteins expression in MKR beta cells. Such loss of
mitochondrial metabolic activity, in the face of up-regulated
glycolysis, could explain the observed oxidative imbalance in these
diabetic beta cells [6].
In conclusion: beta cells show natural variations in glucose
sensitivity. The associated proteomic fingerprints can be quanti-
tatively captured by alternate scanning LC-MS. Though the
associated proteome profiles are partial - with several known
regulators (e.g. glucokinase) below the MS detection limit – they
are consistent with functional state. Beta cells at the upper limits of
the glucose sensitivity distribution are equipped for a higher insulin
synthetic capacity. They express higher levels of all glycolytic
enzymes and shuttles that transport glycolysis-derived reducing
equivalents into the mitochondrial. Molar abundances of mito-
chondrial enzymes however, are not limiting glucose oxidative
flux. More generally, the present study shows that variations in
glucose sensing and associated glucose-regulated functions are
stably reflected in the proteome, supporting the existence of such
phenotypic variations in vivo.
Materials and Methods
Cellular characteristics
Rats were housed according to the Belgian animal welfare
regulations. Animal killing was kept to the strict minimum, after
proper CO2-anesthesia. Use of animal cells and tissues was
approved by the Commissie Proefdiergebruik (CPG) of the Vrije
Universiteit Brussel (VUB), for a project entitled ‘‘in vitro and in
vivo markers for beta cell death and function’’ (CPG approval ID
07-274-3). Rat beta and islet non-beta cells were FACS-purified as
previously described [4,5,26]. These isolates consisted of $95%
endocrine cells and ,2% exocrine cells. Beta cell preparations
consisted of 90% insulin+, 3% glucagon+, 1% somatostatin+ and
2% pancreatic polypeptide+ cells; alpha cells contained 2%
insulin+, 94% glucagon+, 1% somatostatin+ and 2% pancreatic
polypeptide+ cells. Functional data on 3H-tyrosine incorporation,
D-glucose and D-glyceraldehyde oxidation rates in highly and
lowly glucose-responsive beta cells were in part previously reported
[16].
Protein extraction and trypsinization
Freshly isolated rat cells were washed trice with PBS (4uC), and
soluble protein was extracted in 50 ml 0.5% (w/v) RapiGest
detergent in 50 mM ammonium bicarbonate (Waters Corpora-
tion, Milford, MA.) in the presence of Complete Protease Inhibitor
Cocktail (F. Hoffmann–La Roche Ltd, Basel, Switserland) as
specified by manufacturer’s protocol and bovine DNAse II
(Boehringer Ingelheim GmbH, Ingelheim am Rhein, Germany,
2 mg/mL) solution, followed by ultracentrifugation to remove
cellular debris. 25 ml protein extract was reduced with 2.5 ml
100 mM dithiothreitol (DTT) at room temperature for 60 min,
followed by 3 subsequent washes with 400 ml 50 mM ammonium
bicarbonate and 4 ml 100 mM DTT using a 5 KDa cut-off
membrane filter. This step removes protease inhibitors and most
of reduced insulin molecules. Proteins were denatured by heating
at 80uC for 15 min, followed by 30 min at 60uC after addition of
2.5 ml 100 mM DTT and another 30 min at ambient temperature
in the dark after addition of 2.5 ml 200 mM iodoacetamide.
Trypsinization was carried out overnight at 37uC (1:25 w/w
trypsin ratio) in final volume of 100 ml. Finally, RapiGest detergent
was removed by acidifying digest to pH =2 with trifluoroacetic
acid and incubation for 15 min at 37uC.
LC-MS configuration
Nanoscale LC separation of tryptic peptides was performed with
a nanoACQUITY system (Waters Corporation), equipped with a
Symmetry C18 5 mm, 2 cm6180 mm precolumn and an Atlantis
C18 3 mm, 25 cm 675 mm or a Atlantis C18 3 mm, 15 cm
675 mm analytical reversed phase column (Waters Corporation).
The samples, 2 mL full loop injection, were initially transferred
with an aqueous 0.1% formic acid solution to the precolumn at a
flow rate of 4 mL/min for 3 min. Mobile phase A was water with
0.1% formic acid whilst mobile phase B was 0.1% formic acid in
acetonitrile. After desalting and preconcentration, the peptides
were eluted from the precolumn to the analytical column and
separated with a gradient of 3% to 40% mobile phase B over
90 min at a flow rate of 300 nL/min followed by a 10 min rinse
with 90% of mobile phase B. The column was re-equilibrated at
initial conditions for 20 min. The column temperature was
maintained at 35uC. The lock mass compound, [Glu1]-Fibrino-
peptide B, was delivered by the auxiliary pump of the LC system at
250 nL/min at a concentration of 100 fmol/mL to the reference
sprayer of the NanoLockSpray source of the mass spectrometer.
All samples were analyzed in triplicate.
Mass spectrometric analysis of tryptic peptides was performed
using a Synapt MS mass spectrometer (Waters Corporation,
Manchester, UK). For all measurements, the mass spectrometer
was operated in v-mode with a typical resolution of at least 10,000
full width at half maximum. All analyses were performed in
positive mode ESI. The time-of-flight analyzer of the mass
spectrometer was externally calibrated with a NaI mixture from
m/z 50 to 1990. The data was post-acquisition lock mass corrected
using the doubly charged monoisotopic ion of [Glu1]-Fibrinopep-
tide B. The reference sprayer was sampled with a frequency of
30 s. Accurate mass precursor and fragment ion LC-MS data were
collected in data independent, alternate scanning (LC-MSE) mode
of acquisition. This method alternates the energy applied to the
collision cell of the mass spectrometer between a low and elevated
energy state and is described in detail elsewhere [12]. The spectral
acquisition time in each mode was 0.6 s with a 0.02 s interscan
delay. In low energy MS mode, data were collected at constant
collision energy of 4 eV. In elevated energy MS mode, the collision
energy was ramped from 15 eV to 35 eV during each 1s
integration. The radio frequency amplitude applied to the
quadrupole mass analyzer was adjusted such that ions from m/z
300 to 2000 were efficiently transmitted, ensuring that any ions
observed in the LC-MS data less than m/z 300 were known to
arise from dissociations in the collision cell.
LC-MS data processing, protein identification and error
assessment
Continuum LC-MS data were processed and searched using
ProteinLynx GlobalSERVER v2.4 (Waters Corporation). Protein
identifications were obtained by searching a species specific Rattus
norvegicus databases (v15.12, 7,449 entries). Sequence information
of Alcohol dehydrogenase Saccharomyces cerevisiae was added to the
databases to afford the ability to normalize the data sets and to
estimate amounts and concentration [11] and that of known
contaminant proteins (serum albumin Bos taurus and trypsin Sus
scrofa). A decoy was generated on the fly with every database
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search experiment conducted to estimated the protein false
positive rate of identification [43]. Data independent scanning
protein identifications were accepted when more than three
fragment ions per peptide, seven fragment ions per protein and
more than 2 peptides per protein were identified. Furthermore, the
identification of the protein had to occur in at least 2 out of 3
replicate injections. Typical search criteria used for protein
identification included automatic peptide and fragment ion
tolerance settings (approximately 10 and 25 ppm, respectively), 1
allowed missed cleavage, fixed carbamidomethyl-cysteine modifi-
cation and variable methionine oxidation.
Relative molar amount units are used throughout unless stated
otherwise and calculated by dividing the determined molar
amount for a given protein by the summed determined amount
for all identified proteins as this accounts for both technical and
biological variations.
Imprecision (error) attributable to purely analytical variation was
calculated as coefficients of variation on molar values from
triplicate LC-MS injections of the same sample, taken over the 10
to 90% percentile of dynamic range of quantification, i.e.
excluding 10% lowest or highest abundances. Total error -
including the true biological variation, as well as all sample (pre)
processing procedures (islet isolation, beta cell FACS purification,
protein extraction, tryptic digestion and LC-MS analysis) – was
calculated on triplicate injections for all independent isolations
(n = 3), after normalization. Normalization was either on total on
column protein amount, with median (average) error of 22%
(24%) or on that of an endogenous mid concentration range
reference (Ppia), giving median (average) total imprecision of 19%
(20%). Excluding biological variation, the sole technical LC-MS
measurement impression, affords median measurement variation
of 11.4%. To determine the statistically acceptable discrimination
limit between two samples, a normal distribution of the proteome
data was assumed. Full width at half maximum (FWHM) of these
distributions was chosen as statistical discrimination limit to assess
protein expression – a value corresponding to 2.35 times the
median total error (19% times 2.35= 45%).
Selection of reference proteins and geometric
normalization for tissue-comparative analysis
A first criterion to consider a pair of two proteins as reference, is
that they are systematically co-regulated, i.e. that their relative
expression level in different cell types remains constant. Evidently,
proteins that belong to a same functional ontology are likely to be
co-regulated though their absolute levels might vary between cell
types; as second criterion, proteins were selected that were
systematically co-regulated with proteins belonging to a different
functional ontology. The relative expression ratios was calculated
for all n proteins that were identified in all tissues (n = 104) along
with their coefficient of variation between the 4 analyzed tissues
for these (n6 (n-1))/2 unique ratios (Fig. S1a). Protein pairs were
selected with CV% ,40% and extensive co-regulation with at
least 7 other proteins, preferentially belonging to different
functional pathways. In the data set of this study this yielded a
set of638 possible reference proteins (Fig. S1b). Finally, 6 proteins
were chosen with lowest inter-tissue CV% (ranging from 23–38%)
and highest number of co-regulations, not only within their own
functional pathway, but particularly with members of other
functional pathways. From 3 different functional pathways, 2
proteins were chosen: cytoskeleton (Tubb5, Pfn1), cell signaling
(Ywhae, Rab1b) and protein synthesis (Ppia, Hspa8). Each of these 6
references was then sequentially used to normalize all detected
molar protein amounts (Fig. S1). Since reference proteins
themselves also range in abundance over one order of magnitude,
the geometric instead of the arithmetic averages of 6 normalized
ratios were calculated [13].
Supporting Information
Figure S1 Selection algorithm of reference proteins for geomet-
ric normalization in tissue-comparative analysis. A set of 104
proteins was detected in all 4 tissues. For each tissue, the relative
ratio of each candidate reference was calculated with any of the
other candidates. Next, average, standard deviation and associated
coefficient of variation was calculated for each ratio across the 4
tissues. Couples with CV% on their ratio , 40% were marked in
red, others in blue (panel A). Couples with highest number of co-
regulation were subselected (panel B), including functionally co-
regulated proteins e.g. of intermediary metabolism (yellow),
protein synthesis (green), cytoskeleton (blue) or cell signaling (14-
3-3 proteins and small GTPases). Finally, 6 reference proteins
were chosen that showed the most intense co-regulation not only
within their own pathway but also with members of other
functional pathways.
Found at: doi:10.1371/journal.pone.0014214.s001 (1.49 MB
TIF)
Figure S2 Cell size-dependent and -independent functional
properties of beta cell subsets with varying metabolic glucose
responsiveness. Panel A shows FACS-separation of 7.5 mM
glucose-responsive (high NAD(P)H)) and less responsive beta cells
(low NAD(P)H). Panel B: highly responsive beta cells are on the
average larger (forward light scatter, FSC, reflecting cell radius),
and have higher subcellular complexity (side scatter, SSC). Both
populations show similar (oxidized) riboflavin level (FAD, FMN)
but show . 2-fold difference in glucose-induced NAD(P)H. Panel
C: highly (purple bars) responsive beta cells produce 2 to 3 -fold
more insulin than lowly responsive cells (pale blue bars), and this
difference persists (1.9-fold versus lowly responsive cells, n = 3, * p
, 0.05) also after correction (light purple bars) for the 1.3 6 0.1
larger cell size of the high responders. Panel D summarizes main
conclusion of this and earlier studies: highly responsive beta cell
populations show intrinsic activation of glycolysis and insulin
productive machinery, as reflected by 6 1.5-fold higher
GEOnormalized protein levels. On top, these intrinsic phenotypic
differences are further 1.3-fold amplified by the higher cell size of
highly responsive cells, thus accounting the observed 2 to 3-fold
higher insulin synthesis over the 0-10 mM glucose range.
Found at: doi:10.1371/journal.pone.0014214.s002 (1.26 MB
TIF)
Table S1 Overview of protein identifications in tissue-compar-
ative analysis. Table shows gene symbol, protein accession and full
name of all identified proteins, with the relative molar amount
units in respectively alpha, beta, brain and liver. Molar amounts
represent mean of 3 independent experiments, each injected in
triplicate.
Found at: doi:10.1371/journal.pone.0014214.s003 (0.31 MB
XLS)
Table S2 Overview of protein identifications in rat beta cells,
FACS-sorted for higher or lower glucose responsiveness. Table
shows gene symbol, protein accession and full name of all
identified proteins, with the relative molar amount units in
respectively highly (HIGH) or lowly (LOW) glucose responsive
beta cells. Molar amounts represent mean of 3 independent
experiments, each injected in triplicate.
Found at: doi:10.1371/journal.pone.0014214.s004 (0.10 MB
XLS)
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